164 related articles for article (PubMed ID: 591614)
1. The placental transfer of propylthiouracil, methimazole and carbimazole.
Marchant B; Brownlie BE; Hart DM; Horton PW; Alexander WD
J Clin Endocrinol Metab; 1977 Dec; 45(6):1187-93. PubMed ID: 591614
[TBL] [Abstract][Full Text] [Related]
2. 35-S-antithyroid drug concentration and organic binding of iodine in the human thyroid.
Lazarus JH; Marchant B; Alexander WD; Clark DH
Clin Endocrinol (Oxf); 1975 Nov; 4(6):609-15. PubMed ID: 53111
[TBL] [Abstract][Full Text] [Related]
3. Propylthiouracil and methimazole display contrasting pathways of peripheral metabolism in both rat and human.
Taurog A; Dorris ML
Endocrinology; 1988 Feb; 122(2):592-601. PubMed ID: 3338414
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of action of thioureylene antithyroid drugs: factors affecting intrathyroidal metabolism of propylthiouracil and methimazole in rats.
Nakashima T; Taurog A; Riesco G
Endocrinology; 1978 Dec; 103(6):2187-97. PubMed ID: 748042
[TBL] [Abstract][Full Text] [Related]
5. Effects of chronic treatment of intact and hypophysectomized rats with thyroid-stimulating hormone on the metabolism of [35S]methimazole and [35S]propylthiouracil.
Lees JF; Alexander WD
Endocrinology; 1978 Oct; 103(4):1394-400. PubMed ID: 744151
[TBL] [Abstract][Full Text] [Related]
6. Methimazole and propylthiouracil equally cross the perfused human term placental lobule.
Mortimer RH; Cannell GR; Addison RS; Johnson LP; Roberts MS; Bernus I
J Clin Endocrinol Metab; 1997 Sep; 82(9):3099-102. PubMed ID: 9284751
[TBL] [Abstract][Full Text] [Related]
7. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study.
Andersen SL; Olsen J; Wu CS; Laurberg P
J Clin Endocrinol Metab; 2013 Nov; 98(11):4373-81. PubMed ID: 24151287
[TBL] [Abstract][Full Text] [Related]
8. A comparison of potency differences among thyroid peroxidase (TPO) inhibitors to induce developmental toxicity and other thyroid gland-linked toxicities in humans and rats.
Motonaga K; Ota M; Odawara K; Saito S; Welsch F
Regul Toxicol Pharmacol; 2016 Oct; 80():283-90. PubMed ID: 27350053
[TBL] [Abstract][Full Text] [Related]
9. Excretion of methimazole in human milk.
Johansen K; Andersen AN; Kampmann JP; Mølholm Hansen JM; Mortensen HB
Eur J Clin Pharmacol; 1982 Oct; 23(4):339-41. PubMed ID: 6897386
[TBL] [Abstract][Full Text] [Related]
10. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism.
Momotani N; Noh JY; Ishikawa N; Ito K
J Clin Endocrinol Metab; 1997 Nov; 82(11):3633-6. PubMed ID: 9360518
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of thioureylene antithyroid drugs in the rat: possible inactivation of thyroid peroxidase by propylthiouracil.
Shiroozu A; Taurog A; Engler H; Dorris ML
Endocrinology; 1983 Jul; 113(1):362-70. PubMed ID: 6861708
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of 35S-labelled antithyroid drugs in man.
Alexander WD; Evans V; MacAulay A; Gallagher TF; Londono J
Br Med J; 1969 May; 2(5652):290-1. PubMed ID: 4180995
[TBL] [Abstract][Full Text] [Related]
13. [The effects of propylthiouracil on the fetal thyroid and serum concentration in pregnant women].
Feng Q; Gao Y; Li H
Zhonghua Nei Ke Za Zhi; 1996 May; 35(5):295-8. PubMed ID: 9387610
[TBL] [Abstract][Full Text] [Related]
14. Biliary excretion of 35 S-labelled propylthiouracil, methimazole and carbimazole in untreated and pentobarbitone pretreated rats.
Papapetrou PD; Marchant B; Gavras H; Alexander WD
Biochem Pharmacol; 1972 Feb; 21(3):363-77. PubMed ID: 4111354
[No Abstract] [Full Text] [Related]
15. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis.
Wall JR; Fang SL; Kuroki T; Ingbar SH; Braverman LE
J Clin Endocrinol Metab; 1984 May; 58(5):868-72. PubMed ID: 6200492
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of developmental toxicity of propylthiouracil and methimazole.
Mallela MK; Strobl M; Poulsen RR; Wendler CC; Booth CJ; Rivkees SA
Birth Defects Res B Dev Reprod Toxicol; 2014 Aug; 101(4):300-7. PubMed ID: 24980470
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of antithyroid drugs.
Benker G; Reinwein D
Klin Wochenschr; 1982 Jun; 60(11):531-9. PubMed ID: 6180218
[No Abstract] [Full Text] [Related]
18. Propylthiouracil, and methimazole, and carbimazole-related hepatotoxicity.
Akmal A; Kung J
Expert Opin Drug Saf; 2014 Oct; 13(10):1397-406. PubMed ID: 25156887
[TBL] [Abstract][Full Text] [Related]
19. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
20. Effects of developmental hypothyroidism induced by maternal administration of methimazole or propylthiouracil on the immune system of rats.
Nakamura R; Teshima R; Hachisuka A; Sato Y; Takagi K; Nakamura R; Woo GH; Shibutani M; Sawada J
Int Immunopharmacol; 2007 Dec; 7(13):1630-8. PubMed ID: 17996672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
